References
- Best D, Gossop M, Harris J, Farrell M, Finch E, Hoble A, Strang J. Use of non-prescribed methadone and other illicit drugs during methadone maintenance treatment. Drug and alcohol Review 1999, (in press)
- Binchy J M, Molyneux E M, Manning J. Accidental ingestion of methadone by children in Merseyside. British Medical Journal 1994; 308: 1335–1336
- Blenkinsopp A. Community pharmacy services and standards: The 1996 Royal Pharmaceutical Society of Great Britain Survey. Pharmaceutical Journal 1997; 258: 633–635
- British National Formulary No 33. British Medical Association and the Royal Pharmaceutical Society of Great Britain, London 1997
- Byrne A. A reply to Newcombe. Addiction 1997; 92: 220–221
- Department of Health. The Task Force to Review Services for Drug Misusers: Report of an Independent Review of Drug Treatment Services in England. HMSO, London 1996
- Department of Health. Drug misuse and dependence-guidelines on clinical management. The Stationery Office, London 1999
- Farrell M, Ward J, Des Jarlais D C, et al. Methadone maintenance programmes: a review of new data with special reference to impact on HIV transmission. British Medical Journal 1994; 309: 997–1001
- Gruer L, Wilson P, Scott R, et al. General practitioner centred scheme for treatment of opiate dependent drug injectors in Glasgow. British Medical Journal 1997; 314: 1730–1735
- Harding G, Smith F J, Taylor K M G. Injecting drug misusers - pharmacists' attitudes. Journal of Social and Administrative Pharmacy 1992; 9: 35–41
- Harkin K, Quinn C, Bradley F. Storing methadone in babies' bottles puts young children at risk (Letter). British Medical Journal 1999; 318: 329
- Jarman B. Identification of under-privileged areas. British Medical Journal 1983; 286: 1705–1709
- Jarman B. Under-privileged areas: validation and distribution of scores. British Medical Journal 1984; 289: 1587–1592
- Matheson C. Illicit drug users' views of a ‘good’ and ‘bad’ pharmacy service. Journal of Social and Administrative Pharmacy 1998a; 15: 104–112
- Matheson C. Views of illicit drug users on their treatment and behaviour in Scottish community pharmacies: implications for the harm reduction strategy. Health Education Journal 1998b; 57: 31–41
- Rees L, Harding G, Taylor K M G. Supplying injecting equipment to drug misusers: a survey of community pharmacists' attitudes, beliefs and practices. International Journal of Pharmacy Practice 1997; 5: 167–75
- Scott R. Shared care: pharmacists work. Druglink Jan/Feb, 1996; 13–14
- Sheridan J, Barber N. Drug misusers and their attitudes towards and experiences of community pharmacists and community pharmacy services. Pharmaceutical Journal 1996; 257: 325–328
- Sheridan J, Barber N. Drug misuse and HIV prevention: attitudes, knowledge and practices of community pharmacists in two London family health service authorities. Addiction Research 1997; 5(1)11–21
- Sheridan J, Strang J, Barber N, Glanz A. Role of community pharmacies in relation to HIV prevention and drug misuse: findings from the 1995 national survey in England and Wales. British Medical Journal 1996; 313: 272–274
- Strang J, Sheridan J, Barber N. Prescribing oral and injectable methadone to opiate addicts: data from the 1995 National Survey of Community Pharmacies in England and Wales. British Medical Journal 1996; 313: 270–272
- Swensen G. Opioid drug deaths in Western Australia: 1974–1984. Australian Drug and Alcohol Review 1988; 7: 181–185
- Ward J, Mattick R, Hall W, Darke S. The effectiveness and safety of methadone maintenance (letter). Addiction 1996; 91(11)1727–1729